E Fund Management »

Celldex Therapeutics shares owned by E Fund Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by E Fund Management from 13F filings

Historical chart of E Fund Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by E Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by E Fund Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $315k 7.9k 39.66
2023-09-30 $233k 8.5k 27.53
2023-06-30 $375k 11k 33.93
2023-03-31 $298k 8.3k 36.03
2022-12-31 $335k 7.5k 44.60
2022-09-30 $401k 14k 28.09
2022-06-30 $383k 14k 26.97
2022-03-31 $267k 7.8k 34.06
2021-03-31 $105k 5.1k 20.69